In addition, it includes several ferroptosis repressors that might be promising candidates for breast cancer therapy, of which one representative, PDAP1 (PDGFA-associated protein 1), was validated in a xenograft tumor model [18]. Here, PDAP1 is linked to breast carcinoma.